citalopram and lorazepam

citalopram has been researched along with lorazepam in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (52.00)	29.6817
2010's	11 (44.00)	24.3611
2020's	1 (4.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cuenca, PJ; Hoefle, JD; Holt, KR	1
Kaufman, KR; Mohebati, A; Sotolongo, A	1
Kruszewski, SP	1
Jerome, L	1
Cantoni, A; De Panfilis, C; Giannelli, MR; Maggini, C; Marchesi, C	1
Kwon, P; Lefkowitz, W	1
Cho, JH; Choo, CS; Kang, SG; Lee, HJ; Park, YM	1
Corr, PJ; Davis, R; Ettinger, U; Foster, R; Perkins, AM; Williams, SC	1
Al Anazi, T; Al Hayyan, H; Al Hussein, M; Al Modaimegh, H; Al Qahtani, M; Bin Salih, S	1
Greenway, LL; Kuppuswamy, PS; Lauterbach, EC	1
Coulier, B; Devresse, A; Gielen, I; Maldague, P; Pierard, F	1
Lin, JC; Pai, MS; Shiah, IS; Yang, SN	1
Carlo, S; Castaing-Lespier, PA; Sabaté, N; Santos-Cubiñá, J; Torres-Martin, A; Torres-Rodríguez, A	1
Mandal, P; Prakash, S	1
Patterson, B; Van Ameringen, M	1
Uvais, NA	1

Reviews

1 review(s) available for citalopram and lorazepam

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for citalopram and lorazepam

Article	Year
Effect of pharmacological treatment on temperament and character in panic disorder. Psychiatry research, 2008, Mar-15, Volume: 158, Issue:2 Topics: Adult; Anxiety; Character; Citalopram; Female; Follow-Up Studies; GABA Modulators; Humans; Lorazepam; Male; Panic Disorder; Paroxetine; Personality Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Temperament	2008
Effects of Lorazepam and citalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-07, Volume: 29, Issue:40 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Avoidance Learning; Citalopram; Double-Blind Method; Escape Reaction; Fear; Humans; Lorazepam; Male; Personality; Risk Assessment; Task Performance and Analysis; Young Adult	2009

Article

Year

Effect of pharmacological treatment on temperament and character in panic disorder.

Psychiatry research, 2008, Mar-15, Volume: 158, Issue:2

Topics: Adult; Anxiety; Character; Citalopram; Female; Follow-Up Studies; GABA Modulators; Humans; Lorazepam; Male; Panic Disorder; Paroxetine; Personality Disorders; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Temperament

2008

Effects of Lorazepam and citalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-07, Volume: 29, Issue:40

Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Avoidance Learning; Citalopram; Double-Blind Method; Escape Reaction; Fear; Humans; Lorazepam; Male; Personality; Risk Assessment; Task Performance and Analysis; Young Adult

2009

Other Studies

22 other study(ies) available for citalopram and lorazepam

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Seizure secondary to citalopram overdose. The Journal of emergency medicine, 2004, Volume: 26, Issue:2 Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Overdose; Emergency Medical Services; Humans; Lorazepam; Male; Seizures; Suicide, Attempted; Tachycardia, Supraventricular; Trazodone; Treatment Outcome	2004
Pseudoseizures and hysterical stridor. Epilepsy & behavior : E&B, 2004, Volume: 5, Issue:2 Topics: Academic Medical Centers; Adult; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Asthma; Bronchodilator Agents; Child; Child Abuse, Sexual; Citalopram; Conversion Disorder; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Epilepsy; Female; Health Services Misuse; Hospitals, Psychiatric; Humans; Hysteria; Lorazepam; Patient Care Team; Patient Readmission; Patient Transfer; Referral and Consultation; Respiratory Sounds; Seizures; Somatoform Disorders	2004
Conclusions inconsistent with results with citalopram. The American journal of psychiatry, 2005, Volume: 162, Issue:11 Topics: Age Factors; Anxiety Disorders; Citalopram; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Treatment Outcome	2005
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. Pain research & management, 2007,Autumn, Volume: 12, Issue:3 Topics: Amitriptyline; Analgesics; Anti-Ulcer Agents; Anticoagulants; Antidepressive Agents; Anxiety; Cardiotonic Agents; Cataract; Cataract Extraction; Cholecystectomy; Chronic Disease; Citalopram; Digoxin; Female; gamma-Aminobutyric Acid; Heart Failure; Humans; Hypertension; Hysterectomy; Lorazepam; Middle Aged; Mitral Valve Insufficiency; Omeprazole; Ovarian Neoplasms; Pain; Pregabalin; Sterilization, Tubal; Stomach Diseases; Vulvar Diseases	2007
Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use. Pediatric annals, 2008, Volume: 37, Issue:3 Topics: Adult; Anti-Anxiety Agents; Basal Ganglia Diseases; Citalopram; Female; Humans; Infant, Newborn; Lorazepam; Maternal Welfare; Ondansetron; Phenobarbital; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2008
Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzamides; Benzyl Compounds; Bupropion; Citalopram; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Lorazepam	2009
Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report. Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:4 Topics: Acidosis; Anticonvulsants; Citalopram; Depression; Drug Overdose; Female; Humans; Lorazepam; Seizures; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Young Adult	2010
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. Neurocase, 2010, Volume: 16, Issue:5 Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors	2010
Focal parietal necrosis of the sigmoid due to atypical neuroleptics: a case report. Acta gastro-enterologica Belgica, 2012, Volume: 75, Issue:2 Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Citalopram; Clopenthixol; Dibenzothiazepines; Drug Overdose; Enterocolitis, Necrotizing; Humans; Lamotrigine; Lorazepam; Male; Quetiapine Fumarate; Schizoid Personality Disorder; Trazodone; Triazines	2012
Antiretroviral agent entecavir exacerbates major depression. Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:5 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Citalopram; Depressive Disorder, Major; Drug Interactions; Guanine; Hepatitis B, Chronic; Humans; Lorazepam; Male; Psychiatric Status Rating Scales; Suicidal Ideation; Young Adult	2013
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report. Boletin de la Asociacion Medica de Puerto Rico, 2013, Volume: 105, Issue:3 Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Carnitine; Citalopram; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Substitution; Drug Therapy, Combination; Humans; Hyperammonemia; Ketoglutarate Dehydrogenase Complex; Lorazepam; Male; Mood Disorders; Olanzapine; Organic Cation Transport Proteins; Solute Carrier Family 22 Member 5; Valproic Acid	2013
Drug trials in psychiatry: methodological issues. Asian journal of psychiatry, 2014, Volume: 8 Topics: Alcoholism; Chlordiazepoxide; Citalopram; Depressive Disorder; Diabetes Mellitus; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2014
Topiramate augmentation in a patient with obsessive-compulsive disorder. Journal of psychiatry & neuroscience : JPN, 2015, Volume: 40, Issue:5 Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal	2015
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India. The primary care companion for CNS disorders, 2020, 06-25, Volume: 22, Issue:4 Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2	2020